Abstract

Background Neurocognitive deficits are a core feature of psychosis and depression. Despite commonalities in cognitive alterations, it remains unclear if and how the cognitive deficits in patients at clinical high risk for psychosis (CHR) and those with recent-onset psychosis (ROP) are distinct from those seen in recent-onset depression (ROD). Aims This study was carried out within the European project 'Personalized Prognostic Tools for Early Psychosis Management', and aimed to characterise the cognitive profiles of patients with psychosis or depression. Method We examined cognitive profiles for patients with ROP (n = 105), patients with ROD (n = 123), patients at CHR (n = 116) and healthy controls (n = 372) across seven sites in five European countries. Confirmatory factor analysis identified four cognitive factors independent of gender, education and site: speed of processing, attention and working memory, verbal learning and spatial learning. Results Patients with ROP performed worse than healthy controls in all four domains (P < 0.001), whereas performance of patients with ROD was not affected (P > 0.05). Patients at CHR performed worse than healthy controls in speed of processing (P = 0.001) and spatial learning (P = 0.003), but better than patients with ROP across all cognitive domains (all P ≤ 0.01). CHR and ROD groups did not significantly differ in any cognitive domain. These findings were independent of comorbid depressive symptoms, substance consumption and illness duration. Conclusions These results show that neurocognitive abilities are affected in CHR and ROP, whereas ROD seems spared. Although our findings may support the notion that those at CHR have a specific vulnerability to psychosis, future studies investigating broader transdiagnostic risk cohorts in longitudinal designs are needed.

Original languageEnglish
JournalBritish Journal of Psychiatry
Volume223
Issue number4
Pages (from-to)485-492
Number of pages8
ISSN0007-1250
DOIs
Publication statusPublished - 17.10.2023

Funding

N.K., J.K. and R.K.R.S. are currently honorary speakers for Otsuka/Lundbeck. R.U. received grants from the Medical Research Council and the National Institute for Health Research, and personal fees from Sunovion. R.U. and L.K.-I. are members of the British Journal of Psychiatry Editorial Board, but did not take part in the review or decision-making process for this paper. The remaining authors including members of PRONIA Consortium have nothing to disclose. This work was supported by the European Union-FP7 project PRONIA (‘Personalised Prognostic Tools for Early Psychosis Management’; grant number 602152). J.W. was partly supported by the NARSAD Young Investigator Grant through the Brain & Behavior Research Foundation (grant number 28474). P.B. was partly supported by the Italian Ministry of Health (Ricerca Corrente 2023). E. Maggioni was partly funded by the Italian Ministry of Health (grant number GR-2019-12370616).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

  • 2.23-04 Cognitive, Systems and Behavioural Neurobiology
  • 2.23-10 Clinical Psychiatry, Psychotherapy, Child and Adolescent Psychiatry

Fingerprint

Dive into the research topics of 'Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium'. Together they form a unique fingerprint.

Cite this